Taysha Gene Therapies Ratios (2022-2025) | TSHA

Ratios Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Profitability
EBT Margin 7,486.46%4,588.02%2,460.67%4,220.08%-374.29%-1,027.18%-350.02%-417.26%-664.50%-1,788.31%-1,331.94%-902.77%-873.76%-1,254.33%205,800.00%
EBIT Margin 7,388.54%4,491.66%2,361.50%4,135.33%-351.87%-976.37%-342.39%-450.78%-713.28%-1,915.38%-1,448.43%-985.76%-930.54%-1,347.08%226,826.67%
EBITDA Margin 7,388.54%4,491.66%2,361.50%4,135.33%-351.87%-976.37%-342.39%-450.78%-713.28%-1,915.38%-1,448.43%-985.76%-930.54%-1,347.08%226,826.67%
Operating Margin 7,388.54%4,491.66%2,361.50%4,135.33%-351.87%-976.37%-342.39%-450.78%-713.28%-1,915.38%-1,448.43%-985.76%-930.54%-1,347.08%226,826.67%
Net Margin 7,487.65%4,588.43%2,460.76%4,220.54%-374.46%-1,027.06%-2,467.07%1,324.67%-705.39%-1,882.01%-1,427.52%-929.03%-935.23%-1,353.58%218,220.00%
FCF Margin 7,346.13%5,547.24%2,859.93%-950.42%-511.79%-781.59%-378.19%-447.67%-584.52%-1,961.24%-1,205.03%-905.34%-957.56%-1,035.75%161,620.00%
Efficiency
Assets Average 154.15M126.90M118.87M113.94M91.57M138.66M184.25M162.87M176.70M190.31M170.29M149.36M235.85M324.94M
Equity Average 41.62M21.61M5.83M-7.00M-26.03M-43.11M12.91M64.39M81.36M98.83M80.16M63.29M151.89M233.86M
Invested Capital 50.74M32.51M10.70M0.95M-14.95M-37.11M-9.11M74.94M53.85M108.87M88.80M111.53M55.06M248.73M218.99M
Asset Utilization Ratio -0.030.010.050.080.080.090.070.050.050.050.030.02
Leverage & Solvency
Interest Coverage Ratio -73.89-44.92-23.62-41.35-12.05-16.24-11.05-22.79-838.97-788.85-0.00M-906.00-0.00M-0.00M-0.00M
Debt to Equity 0.741.163.5340.01-2.55-1.03-3.650.540.750.350.480.610.770.170.23
Debt Ratio 0.230.260.340.300.380.470.910.230.260.190.240.270.310.120.16
Equity Ratio 0.310.230.100.01-0.15-0.46-0.250.430.350.540.490.450.400.750.69
Times Interest Earned -73.89-44.92-23.62-41.35-12.05-16.24-11.05-22.79-838.97-788.85-0.00M-906.00-0.00M-0.00M-0.00M
Valuation
Enterprise Value 151.58M81.96M42.37M53.24M-12.80M-2.66M39.43M186.53M412.31M245.73M253.80M192.62M432.48M182.62M594.25M
Market Capitalization 250.85M150.83M79.31M141.12M50.63M42.42M203.71M330.92M536.74M418.92M411.94M332.10M549.53M495.87M892.04M
Return Ratios
Return on Sales 43.71%-84.37%-26.24%-10.80%-4.78%-5.57%-5.76%-8.21%-10.15%-11.36%-10.76%-14.96%
Return on Capital Employed -2.90%-2.17%-2.92%2.64%-0.49%-0.65%-0.55%-0.55%-0.63%-0.70%-0.45%-0.34%
Return on Assets -1.40%-1.17%-1.35%-0.82%-0.40%-0.48%-0.42%-0.43%-0.50%-0.55%-0.37%-0.29%
Return on Equity -28.49%19.04%4.76%2.64%-5.72%-1.23%-0.91%-0.82%-1.06%-1.30%-0.57%-0.40%